← FDA Drug Approvals (Drugs@FDA)
LAMICTAL XR
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2009-05-29
Drug application
- FDA Application #
NDA022115- Application type
- New Drug Application
- Brand name
- LAMICTAL XR
- Generic name
- LAMOTRIGINE
- Active ingredients
- LAMOTRIGINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE LLC
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2009-05-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown